🇺🇸 FDA
Pipeline program

Doxycycline EG 200 mg Tabletten

ITM202302

Phase 2 small_molecule active

Quick answer

Doxycycline EG 200 mg Tabletten for Bacterial sexually transmittable diseases (chlamydia, gonorrhea, syphilis) is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
Bacterial sexually transmittable diseases (chlamydia, gonorrhea, syphilis)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials